U.S. markets closed

Anebulo Pharmaceuticals, Inc. (ANEB)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
7.26+0.14 (+1.94%)
At close: 12:04PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts1111
Avg. Estimate-0.03-0.03-0.62-0.5
Low Estimate-0.03-0.03-0.62-0.5
High Estimate-0.03-0.03-0.62-0.5
Year Ago EPSN/AN/AN/A-0.62
Revenue EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts1111
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings HistoryInvalid DateInvalid DateInvalid Date3/30/2021
EPS Est.N/AN/AN/A-0.04
EPS ActualN/AN/AN/A-0.69
DifferenceN/AN/AN/A-0.65
Surprise %N/AN/AN/A-1,625.00%
EPS TrendCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Current Estimate-0.03-0.03-0.62-0.5
7 Days Ago-0.03-0.03-0.62-0.5
30 Days Ago0000
60 Days Ago0000
90 Days Ago0000
EPS RevisionsCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days11N/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesANEBIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.N/AN/AN/AN/A
Current YearN/AN/AN/AN/A
Next Year19.40%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A